Correction: Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade

Related Posts

• Correction: JAK inhibitors and COVID-19

• PD-L1 Expression Predicts Efficacy of PD-1/PD-L1 Inhibitors in Metastatic TNBC

  KEY TAKEAWAYS The phase 3 IMPassion131 trial aimed to analyze the prognostic significance of PD-L1…

• 820 ANV600 is a novel PD-1 targeted IL-2R{beta}/{gamma} agonist that is combinable with therapeutic PD-1 inhibitors

  Background Targeting of stimulatory cytokines to PD-1 expressing tumor infiltrating lymphocytes (TILs) is a promising…